Pmh56 Patient Reported Outcomes (Pro) Collected as Part of the Clinical Process: The Challenge of Administering, Scoring, Storing, and Interpreting PHQ-9 Scores Beyond the Clinical Moment

Abstract

AC, p,0.001). In the last 12 months 36% SC patients had been hospitalized vs 16% AC (p,0.001) and had mean of 2.3 vs 2.0 (p=0.007) comorbidities respectively. Poorvery poor Q-LES-Q overall life satisfaction was reported by 24% SC patients and 11% AC (p,0.001) with overall scores of 49.7 and 56.2 (p,0.001) respectively. Poorer quality of life was also reported through mean EQ5D VAS scores (64.6 SC vs 68.9 AC p=0.01). Patients reported mean WPAI percentages of 34.2 SC vs 31.0 AC for overall work impairment (p=0.44) and 47.5 SC vs 42.7 AC (p=0.038) for daily activities impairment. Conclusions: Poorer outcomes and increased likelihood of hospitalization are evident in Schizophrenia patients who are sometimes compliant with current treatment compared to those who are always compliant.

Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression

“…Change on CGI-S scale has strong face validity, and the usefulness of this measurement approach is reflected in many disorder-specific CGI scales being introduced into clinical trials and observational studies, among them the CGI for schizophrenia (CGI-SCH), 20 for bipolar disorder (CGI-BP), 21,23 and more recently, for schizoaffective disorder (CGI-S-SCA). 22 Although not yet widely used by clinicians, 24 the integration of measurement tools such as MADRS, SDS, and PHQ-9 into routine psychiatric management may enhance the quality of care and improve clinical outcomes. 25 Clinician-rated and/ or patient-rated scales can help characterize the trajectory of the disease course and the effects of treatment.…”